Cosmax Nbt Inc (222040) - Net Assets
Based on the latest financial reports, Cosmax Nbt Inc (222040) has net assets worth ₩60.88 Billion KRW (≈ $41.26 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩303.85 Billion ≈ $205.91 Million USD) and total liabilities (₩242.96 Billion ≈ $164.65 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 222040 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩60.88 Billion |
| % of Total Assets | 20.04% |
| Annual Growth Rate | 13.28% |
| 5-Year Change | -11.77% |
| 10-Year Change | -40.09% |
| Growth Volatility | 121.88 |
Cosmax Nbt Inc - Net Assets Trend (2014–2025)
This chart illustrates how Cosmax Nbt Inc's net assets have evolved over time, based on quarterly financial data. See 222040 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Cosmax Nbt Inc (2014–2025)
The table below shows the annual net assets of Cosmax Nbt Inc from 2014 to 2025. For live valuation and market cap data, see how much is Cosmax Nbt Inc worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩48.84 Billion ≈ $33.10 Million |
-14.82% |
| 2024-12-31 | ₩57.34 Billion ≈ $38.86 Million |
+41.27% |
| 2023-12-31 | ₩40.59 Billion ≈ $27.51 Million |
-6.71% |
| 2022-12-31 | ₩43.51 Billion ≈ $29.49 Million |
-21.40% |
| 2021-12-31 | ₩55.36 Billion ≈ $37.52 Million |
-4.22% |
| 2020-12-31 | ₩57.80 Billion ≈ $39.17 Million |
-17.92% |
| 2019-12-31 | ₩70.41 Billion ≈ $47.72 Million |
-22.54% |
| 2018-12-31 | ₩90.89 Billion ≈ $61.60 Million |
+7.05% |
| 2017-12-31 | ₩84.91 Billion ≈ $57.54 Million |
+4.15% |
| 2016-12-31 | ₩81.52 Billion ≈ $55.25 Million |
+27.07% |
| 2015-12-31 | ₩64.15 Billion ≈ $43.48 Million |
+417.85% |
| 2014-12-31 | ₩12.39 Billion ≈ $8.40 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Cosmax Nbt Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 927.4% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩79.65 Billion | 180.08% |
| Total Equity | ₩44.23 Billion | 100.00% |
Cosmax Nbt Inc Competitors by Market Cap
The table below lists competitors of Cosmax Nbt Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
EDU Holdings Ltd
AU:EDU
|
$92.23 Million |
|
Bundamedik Tbk PT
JK:BMHS
|
$92.26 Million |
|
Nonthavej Hospital Public Company Limited
BK:NTV
|
$92.26 Million |
|
Graha Layar Prima Tbk
JK:BLTZ
|
$92.26 Million |
|
Lakeshore Acquisition III Corp. Ordinary Shares
NASDAQ:LCCC
|
$92.17 Million |
|
NEOWIZ HOLDINGS Corporation
KQ:042420
|
$92.13 Million |
|
Sitowise Group Oyj
HE:SITOWS
|
$92.12 Million |
|
S Connect Co. LTD
KQ:096630
|
$92.10 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cosmax Nbt Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 57,343,069,380 to 44,227,685,490, a change of -13,115,383,890 (-22.9%).
- Net loss of 15,037,231,860 reduced equity.
- Other factors increased equity by 1,921,847,970.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-15.04 Billion | -34.0% |
| Other Changes | ₩1.92 Billion | +4.35% |
| Total Change | ₩- | -22.87% |
Book Value vs Market Value Analysis
This analysis compares Cosmax Nbt Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.08x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 1.68x to 3.08x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩3952.10 | ₩6620.00 | x |
| 2017-12-31 | ₩4116.27 | ₩6620.00 | x |
| 2018-12-31 | ₩4406.29 | ₩6620.00 | x |
| 2019-12-31 | ₩3413.28 | ₩6620.00 | x |
| 2020-12-31 | ₩2801.79 | ₩6620.00 | x |
| 2021-12-31 | ₩2683.61 | ₩6620.00 | x |
| 2022-12-31 | ₩2109.42 | ₩6620.00 | x |
| 2023-12-31 | ₩1761.40 | ₩6620.00 | x |
| 2024-12-31 | ₩2789.76 | ₩6620.00 | x |
| 2025-12-31 | ₩2151.69 | ₩6620.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cosmax Nbt Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -34.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -5.23%
- • Asset Turnover: 1.02x
- • Equity Multiplier: 6.40x
- Recent ROE (-34.00%) is below the historical average (-6.79%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 18.00% | 4.73% | 1.03x | 3.68x | ₩985.76 Million |
| 2015 | 13.39% | 11.06% | 0.68x | 1.79x | ₩2.17 Billion |
| 2016 | 21.11% | 14.25% | 0.66x | 2.24x | ₩9.06 Billion |
| 2017 | 7.38% | 4.60% | 0.68x | 2.35x | ₩-2.22 Billion |
| 2018 | 8.38% | 3.78% | 0.73x | 3.03x | ₩-1.47 Billion |
| 2019 | -25.21% | -9.14% | 0.68x | 4.06x | ₩-24.79 Billion |
| 2020 | -20.95% | -4.54% | 0.87x | 5.28x | ₩-17.89 Billion |
| 2021 | -11.55% | -2.21% | 0.93x | 5.61x | ₩-11.93 Billion |
| 2022 | -30.04% | -3.98% | 1.08x | 6.99x | ₩-17.42 Billion |
| 2023 | -17.93% | -1.95% | 1.11x | 8.29x | ₩-10.11 Billion |
| 2024 | -10.03% | -1.81% | 1.00x | 5.53x | ₩-11.49 Billion |
| 2025 | -34.00% | -5.23% | 1.02x | 6.40x | ₩-19.46 Billion |
Industry Comparison
This section compares Cosmax Nbt Inc's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $483,543,415,493
- Average return on equity (ROE) among peers: 5.97%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cosmax Nbt Inc (222040) | ₩60.88 Billion | 18.00% | 3.99x | $92.21 Million |
| Daehan Flour Mills Co Ltd (001130) | $607.35 Billion | 3.07% | 0.48x | $13.13 Million |
| Daesang Corp (001680) | $472.17 Billion | 0.00% | 2.84x | $419.36 Million |
| Daesang Corp Preference Shares (001685) | $867.27 Billion | 7.45% | 1.66x | $13.73 Million |
| Korea Ind (002140) | $76.12 Billion | 11.88% | 1.05x | $33.02 Million |
| Choheung (002600) | $149.64 Billion | 0.24% | 1.63x | $55.91 Million |
| Sam Yang Foods (003230) | $33.13 Billion | 39.63% | 5.21x | $5.05 Billion |
| Daejoo Inc (003310) | $68.99 Billion | 6.29% | 0.52x | $43.41 Million |
| Harim Holdings Co. Ltd (003380) | $1.69 Trillion | 3.23% | 4.53x | $699.33 Million |
| Hansung Ent (003680) | $54.00 Billion | -4.88% | 3.12x | $17.59 Million |
| Namyang Dairy (003920) | $812.96 Billion | -7.24% | 0.15x | $171.85 Million |
About Cosmax Nbt Inc
Cosmax Nbt, Inc. operates as a health functional food company in South Korea and internationally. It also provides original design and original brand manufacturing services. In addition, the company offers cosmetics, medicines, and medical supplies. It offers its products in tablets, capsules, liquid, and powder supplement form of dosages. The company serves its products through business to busin… Read more